Latest Asx Listing Rules News

FortifAI Limited has raised $5 million through a strategic placement led by a major Australian institutional fund manager, reinforcing its balance sheet and accelerating its AI development and commercialisation plans.

Zip Co Limited has announced a $50 million on-market share buy-back program starting in March 2026, signalling confidence in its financial position and commitment to capital management.

4DS Memory Limited has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information but highlighting ongoing strategic discussions in AI-related technology.

Ronin Resources has clarified the cause behind recent unusual trading activity, confirming no undisclosed information and announcing the end of negotiations on a potential copper-gold project in Argentina.

AuMEGA Metals has successfully upsized its institutional financing to C$30.1 million, anchored by Condire Investors who will hold nearly 20% of the company. The funds will accelerate exploration programs across its Newfoundland gold projects.

PathKey.AI Ltd has responded to ASX inquiries about a recent spike in its share price and trading volume, confirming no undisclosed information is driving the market activity. The company points to its recent strategic update and funding completion as context for investor interest.

Aeris Resources has withdrawn aspirational statements about extending mine life at its Tritton and Jaguar operations following its Peel Resources acquisition announcement, urging investors to exercise caution.

Chariot Resources Ltd has voluntarily suspended trading on the ASX as it finalises a significant financing arrangement, with an announcement expected by 20 February 2026.

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

Empire Resources has successfully raised nearly $2.9 million through the first tranche of its planned $5 million placement, with a second tranche pending shareholder approval in March.

Klevo Rewards Ltd has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to administrative timing issues and pledging enhanced compliance measures.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.